Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
62
GBCI Quote, Financials, Valuation and Earnings
Last price:
$53.20
Seasonality move
:
3.61%
Day range:
$52.70 - $53.97
52-week range:
$36.76 - $53.99
Dividend yield:
2.48%
P/E ratio:
26.68x
P/S ratio:
4.44x
P/B ratio:
1.64x
Volume:
781K
Avg. volume:
1.1M
1-year change:
4.85%
Market cap:
$6.9B
Revenue:
$1.4B
EPS (TTM):
$1.99
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $825.7M | $950.3M | $1.1B | $1.3B | $1.4B | |
| Revenue Growth (YoY) | 3.34% | 15.1% | 19.5% | 11.67% | 13.31% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$638K | $620K | $1.5M | $30K | -- | |
| Operating Expenses | -$358.3M | -$377.2M | -$269.1M | -$231.1M | -$290.2M | |
| Operating Income | $358.3M | $377.2M | $269.1M | $231.1M | $290.2M | |
| Net Interest Expenses | $4.1M | $23.5M | $127.1M | $106.8M | $75.4M | |
| EBT. Incl. Unusual Items | $349.4M | $370.3M | $267.6M | $226.3M | $290.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $64.7M | $67.1M | $44.7M | $36.2M | $51.2M | |
| Net Income to Company | $284.8M | $303.2M | $222.9M | $190.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $284.8M | $303.2M | $222.9M | $190.1M | $239M | |
| Basic EPS (Cont. Ops) | $2.87 | $2.74 | $2.01 | $1.68 | $2.00 | |
| Diluted EPS (Cont. Ops) | $2.86 | $2.74 | $2.01 | $1.68 | $1.99 | |
| Weighted Average Basic Share | $99.3M | $110.8M | $110.9M | $113.2M | $119.8M | |
| Weighted Average Diluted Share | $99.4M | $110.8M | $110.9M | $113.2M | $119.9M | |
| EBITDA | $400M | $448M | $630.7M | $703.2M | -- | |
| EBIT | $368M | $411.5M | $593.6M | $661.5M | $697M | |
| Revenue (Reported) | $825.7M | $950.3M | $1.1B | $1.3B | $1.4B | |
| Operating Income (Reported) | $358.3M | $377.2M | $269.1M | $231.1M | $290.2M | |
| Operating Income (Adjusted) | $368M | $411.5M | $593.6M | $661.5M | $697M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $227.2M | $253.6M | $304.3M | $328.6M | $413.1M | |
| Revenue Growth (YoY) | 5.43% | 11.63% | 20% | 7.98% | 25.72% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$693K | $519K | $1.7M | -- | -- | |
| Operating Expenses | -$68.7M | -$96.3M | -$62.7M | -$72M | -$76.3M | |
| Operating Income | $68.7M | $96.3M | $62.7M | $72M | $76.3M | |
| Net Interest Expenses | $1M | $14.6M | $31.3M | $23.7M | $13.7M | |
| EBT. Incl. Unusual Items | $60M | $97.4M | $62.1M | $73.5M | $76.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.3M | $17.8M | $7.8M | $11.7M | $12.5M | |
| Net Income to Company | $50.7M | $79.7M | $54.3M | $61.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $50.7M | $79.7M | $54.3M | $61.8M | $63.8M | |
| Basic EPS (Cont. Ops) | $0.46 | $0.72 | $0.49 | $0.54 | $0.49 | |
| Diluted EPS (Cont. Ops) | $0.46 | $0.72 | $0.49 | $0.54 | $0.49 | |
| Weighted Average Basic Share | $110.7M | $110.8M | $110.9M | $113.4M | $130M | |
| Weighted Average Diluted Share | $110.8M | $110.9M | $110.9M | $113.5M | $130.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $65.2M | $118.5M | $169.2M | $179.1M | $183M | |
| Revenue (Reported) | $227.2M | $253.6M | $304.3M | $328.6M | $413.1M | |
| Operating Income (Reported) | $68.7M | $96.3M | $62.7M | $72M | $76.3M | |
| Operating Income (Adjusted) | $65.2M | $118.5M | $169.2M | $179.1M | $183M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $825.7M | $950.3M | $1.1B | $1.3B | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$638K | $620K | $1.5M | $30K | -- | |
| Operating Expenses | -$358.5M | -$374.3M | -$269.1M | -$231.1M | -$299.3M | |
| Operating Income | $358.5M | $374.3M | $269.1M | $231.1M | $299.3M | |
| Net Interest Expenses | $4.1M | $23.5M | $127.1M | $106.8M | $75.4M | |
| EBT. Incl. Unusual Items | $349.4M | $370.3M | $267.6M | $226.3M | $290.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $64.7M | $67.1M | $44.7M | $36.2M | $51.2M | |
| Net Income to Company | $284.8M | $303.2M | $222.9M | $190.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $284.8M | $303.2M | $222.9M | $190.1M | $239M | |
| Basic EPS (Cont. Ops) | $2.91 | $2.74 | $2.01 | $1.68 | $2.00 | |
| Diluted EPS (Cont. Ops) | $2.91 | $2.74 | $2.01 | $1.68 | $1.99 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $368M | $411.5M | $593.6M | $661.5M | $697M | |
| Revenue (Reported) | $825.7M | $950.3M | $1.1B | $1.3B | $1.4B | |
| Operating Income (Reported) | $358.5M | $374.3M | $269.1M | $231.1M | $299.3M | |
| Operating Income (Adjusted) | $368M | $411.5M | $593.6M | $661.5M | $697M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $950.3M | $1.1B | $1.3B | $1.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $620K | $1.5M | $30K | -- | -- | |
| Operating Expenses | -$374.3M | -$269.1M | -$231.1M | -$299.3M | -- | |
| Operating Income | $374.3M | $269.1M | $231.1M | $299.3M | -- | |
| Net Interest Expenses | $23.5M | $127.1M | $106.8M | $75.4M | -- | |
| EBT. Incl. Unusual Items | $370.3M | $267.6M | $226.3M | $290.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $67.1M | $44.7M | $36.2M | $51.2M | -- | |
| Net Income to Company | $303.2M | $222.9M | $190.1M | $107.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $303.2M | $222.9M | $190.1M | $239M | -- | |
| Basic EPS (Cont. Ops) | $2.74 | $2.01 | $1.68 | $2.00 | -- | |
| Diluted EPS (Cont. Ops) | $2.74 | $2.01 | $1.68 | $1.99 | -- | |
| Weighted Average Basic Share | $443M | $443.5M | $452.7M | $478.8M | -- | |
| Weighted Average Diluted Share | $443.3M | $443.6M | $453M | $479.2M | -- | |
| EBITDA | $95.3M | $128.6M | $159.2M | $174.2M | -- | |
| EBIT | $411.5M | $593.6M | $661.5M | $697M | -- | |
| Revenue (Reported) | $950.3M | $1.1B | $1.3B | $1.4B | -- | |
| Operating Income (Reported) | $374.3M | $269.1M | $231.1M | $299.3M | -- | |
| Operating Income (Adjusted) | $411.5M | $593.6M | $661.5M | $697M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $198.1M | $300.2M | $246.5M | $268.7M | $321.5M | |
| Short Term Investments | $9.2B | $5.3B | $4.8B | $3.7B | -- | |
| Accounts Receivable, Net | $76.7M | $83.5M | $94.5M | $99.3M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $514.4M | $485.6M | $1.5B | $948.8M | $1.4B | |
| Property Plant And Equipment | $372.6M | $398.1M | $421.8M | $468.2M | $561.8M | |
| Long-Term Investments | $361.1M | $204.2M | $1.1B | $713.7M | $995.7M | |
| Goodwill | $985.4M | $985.4M | $985.4M | $1.1B | -- | |
| Other Intangibles | $52.3M | $41.6M | $31.9M | $51.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $26B | $26.7B | $27.8B | $28B | $32B | |
| Accounts Payable | $2.4M | $4.3M | $125.9M | $33.6M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.6B | $19.3B | $21.2B | $21.2B | $20.1B | |
| Long-Term Debt | $219.1M | $249.7M | $252M | $249.1M | $320.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.8B | $23.9B | $24.8B | $24.7B | $27.8B | |
| Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.3M | |
| Other Common Equity Adj | $27.4M | -$468.8M | -$374.1M | -$309.3M | -- | |
| Common Equity | $3.2B | $2.8B | $3B | $3.2B | $4.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.2B | $2.8B | $3B | $3.2B | $4.2B | |
| Total Liabilities and Equity | $26B | $26.7B | $27.8B | $28B | $32B | |
| Cash and Short Terms | $9.6B | $5.7B | $6.1B | $4.6B | -- | |
| Total Debt | $219.3M | $253.7M | $255.9M | $253.1M | $320.6M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $198.1M | $300.2M | $246.5M | $268.7M | $321.5M | |
| Short Term Investments | $9.2B | $5.3B | $4.8B | $3.7B | -- | |
| Accounts Receivable, Net | $76.7M | $83.5M | $94.5M | $99.3M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $514.4M | $485.6M | $1.5B | $948.8M | $1.4B | |
| Property Plant And Equipment | $372.6M | $398.1M | $421.8M | $468.2M | $561.8M | |
| Long-Term Investments | $361.1M | $204.2M | $1.1B | $713.7M | $995.7M | |
| Goodwill | $985.4M | $985.4M | $985.4M | $1.1B | -- | |
| Other Intangibles | $52.3M | $41.6M | $31.9M | $51.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $25.9B | $26.7B | $27.8B | $28B | $32B | |
| Accounts Payable | $2.4M | $4.3M | $125.9M | $33.6M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.6B | $19.3B | $21.2B | $21.2B | $20.1B | |
| Long-Term Debt | $219.1M | $249.7M | $252M | $249.1M | $320.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.8B | $23.9B | $24.8B | $24.7B | $27.8B | |
| Common Stock | $1.1M | $1.1M | $1.1M | $1.1M | $1.3M | |
| Other Common Equity Adj | $27.4M | -$468.8M | -$374.1M | -$309.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $3.2B | $2.8B | $3B | $3.2B | $4.2B | |
| Total Liabilities and Equity | $25.9B | $26.7B | $27.8B | $28B | $32B | |
| Cash and Short Terms | $9.6B | $5.7B | $6.1B | $4.6B | -- | |
| Total Debt | $219.3M | $253.7M | $255.9M | $253.1M | $320.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $266.4M | $284.8M | $303.2M | $222.9M | $190.1M | |
| Depreciation & Amoritzation | $30.8M | $32M | $36.5M | $37.1M | $41.7M | |
| Stock-Based Compensation | $3.6M | $4.3M | $5.4M | $5.9M | $5.7M | |
| Change in Accounts Receivable | -$17.7M | $5.1M | -$6.9M | -$11M | $877K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $166.8M | $325.3M | $368.9M | $386.6M | $185.1M | |
| Capital Expenditures | $11.7M | $9.4M | $23.2M | $49.3M | $48.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.5B | -$3.7B | -$1.3B | -$93.4M | $566.1M | |
| Dividends Paid (Ex Special Dividend) | $131.3M | $145.6M | $157.5M | $146.7M | $150M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $30.6M | $3.5M | $1.8B | $2.7B | $1.8B | |
| Long-Term Debt Repaid | -$38.6M | -- | -- | -$1.8B | -$2.8B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.1M | -$1.6M | -$1.7M | -$1.8M | -$1.6M | |
| Cash From Financing | $3.7B | $3.1B | $845.4M | $659.1M | -$1.3B | |
| Beginning Cash (CF) | $331M | $633.1M | $437.7M | $402M | $1.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $302.2M | -$195.5M | -$35.7M | $952.3M | -$505.9M | |
| Ending Cash (CF) | $633.1M | $437.7M | $402M | $1.4B | $848.4M | |
| Levered Free Cash Flow | $155.1M | $315.8M | $345.7M | $337.3M | $136.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $50.7M | $79.7M | $54.3M | $61.8M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $909K | $1.1M | $1.4M | $1.3M | -- | |
| Change in Accounts Receivable | $9.3M | $9.8M | $10M | $14.9M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $96.2M | $94.2M | $99.7M | $96.6M | -- | |
| Capital Expenditures | $5.2M | $6.3M | $12.8M | $20.9M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$487.3M | $76.4M | $126.9M | $61.2M | -- | |
| Dividends Paid (Ex Special Dividend) | $70.8M | $73.1M | $73.2M | $74.9M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.5M | $1.8B | $3.3M | -$883K | -- | |
| Long-Term Debt Repaid | $6.9M | -- | $4.2M | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$33K | -$104K | $4K | -$167K | -- | |
| Cash From Financing | $479.8M | -$193.8M | -$544.3M | -$297.3M | -- | |
| Beginning Cash (CF) | $348.9M | $425.2M | $1.7B | $987.8M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $88.8M | -$23.2M | -$317.8M | -$139.4M | -- | |
| Ending Cash (CF) | $437.7M | $402M | $1.4B | $848.4M | -- | |
| Levered Free Cash Flow | $91M | $87.8M | $86.9M | $75.7M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $284.8M | $303.2M | $222.9M | $190.1M | -- | |
| Depreciation & Amoritzation | $32M | $36.5M | $37.1M | $41.7M | -- | |
| Stock-Based Compensation | $4.3M | $5.4M | $5.9M | $5.7M | -- | |
| Change in Accounts Receivable | $5.1M | -$6.9M | -$11M | $877K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $325.3M | $368.9M | $386.6M | $185.1M | -- | |
| Capital Expenditures | $9.4M | $23.2M | $49.3M | $48.3M | $19.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.7B | -$1.3B | -$93.4M | $566.1M | -- | |
| Dividends Paid (Ex Special Dividend) | $145.6M | $157.5M | $146.7M | $150M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.8B | $2.7B | $1.8B | -- | |
| Long-Term Debt Repaid | -- | -- | -$1.8B | -$2.8B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.6M | -$1.7M | -$1.8M | -$1.6M | -- | |
| Cash From Financing | $3.1B | $845.4M | $659.1M | -$1.3B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$195.5M | -$35.7M | $952.3M | -$505.9M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $315.8M | $345.7M | $337.3M | $136.8M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $303.2M | $222.9M | $190.1M | $107.3M | -- | |
| Depreciation & Amoritzation | $8.6M | $9.3M | $9.9M | $22.2M | -- | |
| Stock-Based Compensation | $5.4M | $5.9M | $5.7M | $5M | -- | |
| Change in Accounts Receivable | -$6.9M | -$11M | $877K | -$2.6M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $368.9M | $386.6M | $185.1M | $250.9M | -- | |
| Capital Expenditures | $23.2M | $49.3M | $48.3M | $19.8M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3B | -$93.4M | $566.1M | $320M | -- | |
| Dividends Paid (Ex Special Dividend) | $157.5M | $146.7M | $150M | $77M | -- | |
| Special Dividend Paid | $100K | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.8B | $2.7B | $1.8B | $304K | -- | |
| Long-Term Debt Repaid | -- | -$1.8B | -$2.8B | -$595M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.7M | -$1.8M | -$1.6M | -$2.5M | -- | |
| Cash From Financing | $845.4M | $659.1M | -$1.3B | -$565M | -- | |
| Beginning Cash (CF) | $1.7B | $4.7B | $3.9B | $1.8B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$35.7M | $952.3M | -$505.9M | $5.8M | -- | |
| Ending Cash (CF) | $1.7B | $5.6B | $3.4B | $1.9B | -- | |
| Levered Free Cash Flow | $345.7M | $337.3M | $136.8M | $231.1M | -- | |
Get GBCI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GBCI
Sector
P/E ratio
26.68x
12.54x
PEG ratio
1.41x
0.32x
P/B ratio
1.64x
1.15x
Price / LTM sales
4.44x
1.86x
Growth Metrics
GBCI
Sector
Revenue growth
25.72%
5.54%
Earnings growth
-9.91%
11.36%
Revenue (5-year growth)
12.45%
8.68%
Earnings forecast
$0.62
$0.64
Profitability
GBCI
Sector
Profitability FY 2025
--
--
Return on invested capital
3.43%
5.2%
Return on assets
0.82%
1.03%
Return on equity
6.69%
9.91%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Apr
23
Estimated Next Earnings Date
Apr
23
Balance Sheet
GBCI
Sector
Total cash
$4.8B
$407.2M
Short term investments
$3.7B
$192.4M
Total assets
$32B
$3.1B
Long term debt
$320.6M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
